Add to ORKGThe online version of this article, along with updated information and services, is located on th
Background Transplacental fetal treatment of immune‐mediated fetal heart disease, including third‐de...
Copyright © 2014 Annette Wacker-Gussmann et al. This is an open access article distributed under the...
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Background—Untreated isolated fetal complete atrioventricular block (CAVB) has a significant mortali...
The online version of this article, along with updated information and services, is located on th
This article describes a fetal presentation at 24 weeks and 5 days postmenstrual age of a congenital...
Objective: This article aims to present updated therapeutic options for fetal congenital heart dise...
The online version of this article, along with updated information and services, is located on th
Objectives: to analyse retrospectively the data of fetuses diagnosed with isolated complete atrioven...
The online version of this article, along with updated information and services, is located on th
Background Transplacental fetal treatment of immune-mediated fetal heart disease, including third-de...
Introduction: Antibody-mediated complete atrioventricular block (CAVB) is considered irreversible. W...
Fetal cardiac interventions: an update of therapeutic options Intervenções cardíacas fetais: atualiz...
The online version of this article, along with updated information and services, is located on th
Background Transplacental fetal treatment of immune‐mediated fetal heart disease, including third‐de...
Copyright © 2014 Annette Wacker-Gussmann et al. This is an open access article distributed under the...
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Background—Untreated isolated fetal complete atrioventricular block (CAVB) has a significant mortali...
The online version of this article, along with updated information and services, is located on th
This article describes a fetal presentation at 24 weeks and 5 days postmenstrual age of a congenital...
Objective: This article aims to present updated therapeutic options for fetal congenital heart dise...
The online version of this article, along with updated information and services, is located on th
Objectives: to analyse retrospectively the data of fetuses diagnosed with isolated complete atrioven...
The online version of this article, along with updated information and services, is located on th
Background Transplacental fetal treatment of immune-mediated fetal heart disease, including third-de...
Introduction: Antibody-mediated complete atrioventricular block (CAVB) is considered irreversible. W...
Fetal cardiac interventions: an update of therapeutic options Intervenções cardíacas fetais: atualiz...
The online version of this article, along with updated information and services, is located on th
Background Transplacental fetal treatment of immune‐mediated fetal heart disease, including third‐de...
Copyright © 2014 Annette Wacker-Gussmann et al. This is an open access article distributed under the...
The online version of this article, along with updated information and services, is located on th